Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Multicenter, Randomized, Double-blind, Dose-ranging, Placebo-controlled Study to Assess the Safety and Efficacy of S-309309 in Obese Adults

NCT05925114 is registered in ClinicalTrials.gov with Shionogi as lead sponsor.

NCT NCT05925114
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05925114 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Multicenter, Randomized, Double-blind, Dose-ranging, Placebo-controlled Study to Assess the Safety and Efficacy of S-309309 in Obese Adults
Lead sponsor
Shionogi
Phase
Phase 2
Overall status
Completed
Start date
June 21, 2023
Completion date
May 17, 2024
Enrollment
365 (actual)
Sites
49

Conditions

As the registry lists them; a condition with its own page is linked.

obesity